Zein‐Ceria Hybrid Microparticles Enable Long‐Term ROS‐Scavenging Oxygenation for Osteogenic Microtissues Engineering

H Hayeon Byun (Transplantation Research Center (Y.C., Y.Y., S.J., G.S., S.M.K., H.B., X.L., A.J.S., M.Y., Y.I., J.Z., V.K., R.A.), Boston, MA.) S Seok Gyu Han (Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA) N Niels Willemen (Leijten Laboratory Department of Bioengineering Technologies Faculty of Science and Technology TechMed Centre University Twente Enschede Netherlands) E Eunji Park K Kannan Govindaraj (Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA) S Seol‐Ha Jeong (Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA) O Oju Jeon (Department of Biomedical Engineering University of Illinois Chicago Chicago Illinois USA) E Eben Alsberg (Department of Biomedical Engineering University of Illinois Chicago Chicago Illinois USA) J Jeroen Leijten (Leijten Laboratory Department of Bioengineering Technologies Faculty of Science and Technology TechMed Centre University Twente Enschede Netherlands) H Heungsoo Shin (Department of Bioengineering Hanyang University Seoul Republic of Korea) S Su Ryon Shin (Division of Engineering in Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Cambridge Massachusetts USA)

Abstract

ABSTRACT Oxygen‐ and biological cue‐deprived microenvironments formed during tissue regeneration severely limit cell survival and differentiation, resulting in long‐term structural and functional deficits. However, conventional oxygen‐releasing biomaterials often exhibit burst releases, with the vast majority of oxygen released during the first few days, which is associated with high levels of concomitant reactive oxygen species (ROS)‐derived oxidative stress and a lack of bioactive factors. Here, we report a hierarchically engineered zein‐ceria hybrid microparticle that enables sustained ROS‐neutral oxygenation for over 40 days and supplies an osteoinductive factor. A hydrophobic zein core stabilizes the oxygen source and suppresses burst release, while a ceria nanozyme‐integrated shell continuously scavenges excess ROS via redox cycling. Biocompatible surface engineering enables the seamless integration of these microparticles within stem cell spheroids, which markedly enhances cell survival under anoxia. Their biofunctional surface supports enzymatic protein immobilization under physiological conditions, enabling spontaneous osteogenesis of engineered bone microtissues. In a severely oxygen‐deprived mouse calvarial defect model, the engineered microtissues accelerated bone regeneration. Our biomaterial design enables control of burst oxygen release, ROS modulation, and growth factor release, built on a zein‐ceria double‐layer architecture, offering a modular platform that broadens the utility of oxygenating and bioactive micromaterials in regenerative medicine.

Article Details

Volume / Issue Vol. 38, Issue 44
Published August 01, 2026
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (11)

H

Hayeon Byun

Transplantation Research Center (Y.C., Y.Y., S.J., G.S., S.M.K., H.B., X.L., A.J.S., M.Y., Y.I., J.Z., V.K., R.A.), Boston, MA.

S

Seok Gyu Han

Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA

N

Niels Willemen

Leijten Laboratory Department of Bioengineering Technologies Faculty of Science and Technology TechMed Centre University Twente Enschede Netherlands

E

Eunji Park

K

Kannan Govindaraj

Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA

S

Seol‐Ha Jeong

Division of Engineering in Medicine Department of Medicine Harvard Medical School and Brigham and Women's Hospital Cambridge Massachusetts USA

O

Oju Jeon

Department of Biomedical Engineering University of Illinois Chicago Chicago Illinois USA

E

Eben Alsberg

Department of Biomedical Engineering University of Illinois Chicago Chicago Illinois USA

J

Jeroen Leijten

Leijten Laboratory Department of Bioengineering Technologies Faculty of Science and Technology TechMed Centre University Twente Enschede Netherlands

H

Heungsoo Shin

Department of Bioengineering Hanyang University Seoul Republic of Korea

S

Su Ryon Shin

Division of Engineering in Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Cambridge Massachusetts USA